EUVIMEDEUVIMED entdecken
Fallbericht

Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors

M Štork, J Kotašková, E Ondroušková, M Borský, A Marečková, N Sendlerová, J Mayerová, M Brada, I Boichuk, K Menšíková, Z Adam, M Krejčí und 10 weitere

Klinicka onkologie · 2025

DOI: 10.48095/ccko2025390 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Klinicka onkologie, 2025. Verfasst von M Štork und 21 weiteren Autor:innen. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Multiple Myeloma, Precision Medicine, Protein Kinase Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafMultiple MyelomaPrecision MedicineProtein Kinase InhibitorsHumansMutationBenzimidazolesMaleMiddle Aged

Stichwörter der Autor:innen

multiple myelomaBRAF inhibitorsNext-generation sequencingnext generation sequencingprecision medicine

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProtein Kinase InhibitorsbinimetinibBenzimidazoles

Zitieren

APA

Štork, M., Kotašková, J., Ondroušková, E., Borský, M., Marečková, A., Sendlerová, N., Mayerová, J., Brada, M., Boichuk, I., Menšíková, K., Adam, Z., Krejčí, M., Sandecká, V., Jelínková, Z., Krtička, M., Nekuda, V., Bilčíková, M., Hrabčáková, V., Vojtková, L., …, & Pour, L. (2025). Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors. Klinicka onkologie. https://doi.org/10.48095/ccko2025390

Vancouver

Štork M, Kotašková J, Ondroušková E, Borský M, Marečková A, Sendlerová N, et al. Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors. Klinicka onkologie. 2025. doi:10.48095/ccko2025390

BibTeX
@article{tork2025,
  author = {Štork, M and Kotašková, J and Ondroušková, E and Borský, M and Marečková, A and Sendlerová, N and Mayerová, J and Brada, M and Boichuk, I and Menšíková, K and Adam, Z and Krejčí, M and Sandecká, V and Jelínková, Z and Krtička, M and Nekuda, V and Bilčíková, M and Hrabčáková, V and Vojtková, L and Jarošová, M and Šlampa, P and Pour, L},
  title = {Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors},
  journal = {Klinicka onkologie},
  year = {2025},
  doi = {10.48095/ccko2025390}
}
Kostenlos starten →